和此前的一些基因编辑类型不同，新CRISPR技术相对便宜，如果当前的禁令放松，生物科技企业有可能会竞相填补市场。
The new CRISPR technique, unlike some previous types of gene editing, is relatively cheap, and if current bans were relaxed, biotechnology firms would likely rush to fill the market.